Diabetic peripheral neuropathy
Can omega-3s improve diabetic nerve damage or symptoms?
A 2025 Cochrane review found inadequate data to determine effects on nerve impairment and little or no apparent symptom or quality-of-life benefit.
Insufficient evidence○ Not yet scored
Updated September 24, 2026 · Editorial attribution: PV Griscom, M.Sc. · Independent clinical review pending
The question behind the headline
Adults with diabetes and distal symmetrical peripheral neuropathy.
What the finding does—and doesn’t—tell us
A nerve biomarker and relief of pain, numbness or functional limitations are different outcomes.
GO TO THE EVIDENCE
Read the underlying research.
Selected sources, not an exhaustive reference list. Research record or abstract screening only; full-text efficacy appraisal is pending. Source publication dates may precede this page’s update date.
Three questions to take forward
- Was the study population similar to the person or situation I have in mind?
- Did it measure an outcome people feel or experience, or only a laboratory marker?
- How do formulation, usual care, absolute benefit and adverse effects change the interpretation?
Study doses describe experiments; they are not personal dosing advice. Explore safety and limitations ↗